COO - The Cooper Companies, Inc.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
San Ramon,
United States
Type: Equity
COO price evolution
COO
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $109.7 | $112.4 | ||
| Short term investments | ||||
| Net receivables | $717 | $739 | $688.7 | $651 |
| Inventory | $802.7 | $779.3 | $775.4 | $747.5 |
| Total current assets | $1951.5 | $1926.7 | $1859 | $1793.9 |
| Long term investments | ||||
| Property, plant & equipment | $2124.1 | $1747.6 | $1709.3 | $1682.2 |
| Goodwill & intangible assets | $5564 | $5558.2 | ||
| Total noncurrent assets | $10181.3 | $10188.4 | ||
| Total investments | ||||
| Total assets | $12315.2 | $12108 | $12047.4 | $12032.6 |
| Current liabilities | ||||
| Accounts payable | $260.5 | $222 | $230.7 | $202.3 |
| Deferred revenue | $317.2 | $310.3 | ||
| Short long term debt | $40.8 | $41.7 | ||
| Total current liabilities | $1022.8 | $969.5 | $952.5 | $964.9 |
| Long term debt | $2550.4 | $2591.6 | $2671.3 | $2726.2 |
| Total noncurrent liabilities | $3213.3 | $3291 | ||
| Total debt | $2632.4 | $2713 | ||
| Total liabilities | $4231.8 | $4182.8 | $4243.7 | $4337.5 |
| Shareholders' equity | ||||
| Retained earnings | $7268.4 | $7150.9 | $7046.2 | $6957.3 |
| Other shareholder equity | -$421.7 | $7925.2 | -$422.6 | -$422 |
| Total shareholder equity | $7925 | $7803.7 | ||
| (in millions $) | 1 Dec 2024 | 31 Dec 2023 | 1 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $120.8 | $138.2 | $95.9 | |
| Short term investments | ||||
| Net receivables | $717 | $609.7 | $557.8 | $515.3 |
| Inventory | $802.7 | $735.6 | $628.7 | $585.6 |
| Total current assets | $1951.5 | $1704.9 | $1533.6 | $1465.3 |
| Long term investments | ||||
| Property, plant & equipment | $2124.1 | $1632.6 | $1663 | $1604.6 |
| Goodwill & intangible assets | $5334.8 | $5494.8 | $3845.5 | |
| Total noncurrent assets | $9954 | $9958.7 | $8140.9 | |
| Total investments | ||||
| Total assets | $12315.2 | $11658.9 | $11492.3 | $9606.2 |
| Current liabilities | ||||
| Accounts payable | $260.5 | $352.1 | $248.8 | $301 |
| Deferred revenue | $307.8 | $291.9 | ||
| Short long term debt | $45.4 | $412.6 | $118.6 | |
| Total current liabilities | $1022.8 | $969 | $1280.2 | $732.1 |
| Long term debt | $2550.4 | $2523.8 | $2350.8 | $1627.8 |
| Total noncurrent liabilities | $3138.9 | $3037.4 | $1932.1 | |
| Total debt | $2569.2 | $2763.4 | $1746.4 | |
| Total liabilities | $4231.8 | $4107.9 | $4317.8 | $2664.2 |
| Shareholders' equity | ||||
| Retained earnings | $7268.4 | $6876.1 | $6584.9 | $6202.1 |
| Other shareholder equity | -$421.7 | -$453.8 | -$466.8 | -$341.3 |
| Total shareholder equity | $7550.8 | $7174.5 | $6941.8 | |
| (in millions $) | 31 Jan 2025 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1002.8 | $942.6 | $931.6 | |
| Cost of revenue | ||||
| Gross Profit | $663 | $631.2 | $623.8 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $470.5 | $469.5 | $470.7 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $59 | $41.1 | $38.8 | |
| Interest expense | -$28.5 | -$31.4 | -$31.1 | |
| Net income | ||||
| Net income | $104.7 | $88.9 | $81.2 | |
| Income (for common shares) | ||||
| (in millions $) | 1 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3895.4 | $3593.2 | $3308.4 | |
| Cost of revenue | $1235.3 | $1168.8 | ||
| Gross Profit | $2595.7 | $2357.9 | $2139.6 | |
| Operating activities | ||||
| Research & development | $137.4 | $110.3 | ||
| Selling, general & administrative | $1501.2 | $1342.2 | ||
| Total operating expenses | $1890 | $1824.8 | $1632 | |
| Operating income | $533.1 | $507.6 | ||
| Income from continuing operations | ||||
| EBIT | $518.2 | $532.6 | ||
| Income tax expense | $190 | $118.7 | $89.5 | |
| Interest expense | -$119.5 | $105.3 | $57.3 | |
| Net income | ||||
| Net income | $392.3 | $294.2 | $385.8 | |
| Income (for common shares) | $294.2 | $385.8 | ||
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$764.6 | -$523 | -$398.9 | -$324.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $39.2 | $67.6 | $155.2 | $212.3 |
| Effect of exchange rate | $2.9 | $3.1 | $1.7 | $3.5 |
| Change in cash and equivalents | -$13.2 | -$11.1 | -$8.3 | $14.4 |
| (in millions $) | 1 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $294.2 | $385.8 | $2944.7 | |
| Operating activities | ||||
| Depreciation | $407.7 | $378.3 | $343.1 | |
| Business acquisitions & disposals | -$56.5 | -$1589.2 | -$235.9 | |
| Stock-based compensation | $62.1 | $54.2 | $43.8 | |
| Total cash flows from operations | $607.5 | $692.4 | $738.6 | |
| Investing activities | ||||
| Capital expenditures | -$392.5 | -$242 | -$214.4 | |
| Investments | ||||
| Total cash flows from investing | -$764.6 | -$449 | -$1831.2 | -$450.3 |
| Financing activities | ||||
| Dividends paid | -$3 | -$3 | -$3 | |
| Sale and purchase of stock | $9.9 | -$79.2 | $1.5 | |
| Net borrowings | -$180.8 | $1278.8 | -$309.8 | |
| Total cash flows from financing | $39.2 | -$173.9 | $1193.7 | -$311.4 |
| Effect of exchange rate | $2.9 | -$2.3 | -$12.9 | $2.9 |
| Change in cash and equivalents | -$13.2 | -$17.7 | $42 | -$20.2 |
News
Fundamentals
| Market cap | $18.03B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 199.60M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.91 |
| Quick ratio | 1.12 |